Merck KGaA (OTCMKTS:MKGAY) has been given an average rating of “Hold” by the nine brokerages that are presently covering the firm, Marketbeat reports. Three research analysts have rated the stock with a sell rating, three have issued a hold rating and three have assigned a buy rating to the company.
A number of brokerages recently weighed in on MKGAY. UBS Group cut shares of Merck KGaA from a “neutral” rating to a “sell” rating in a research note on Tuesday. DZ Bank cut shares of Merck KGaA from a “buy” rating to a “hold” rating in a research note on Friday, July 9th.
Shares of OTCMKTS:MKGAY opened at $38.36 on Friday. The firm has a fifty day moving average price of $38.36 and a 200 day moving average price of $38.36. Merck KGaA has a 1-year low of $32.53 and a 1-year high of $42.02.
Merck KGaA is a science and technology company, which engages in the manufacture of pharmaceutical and chemical products. It operates through the following sectors: Healthcare, Life Science, Performance Materials and Corporate and Other. The Healthcare sector discovers, develops, and produces prescription medicines used to treat cancer, multiple sclerosis, and infertility.
Further Reading: Should You Consider an Index Fund?
Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.